Annals On Call - Evidence-Based Care of Substance Use Disorders
Authors: Robert M. Centor, Stefan G. Kertesz
Journal: Annals of Internal Medicine (2022)

Web ExclusivesMay 2022Annals On Call - Evidence-Based Care of Substance Use DisordersFREERobert M. Centor, MD and Stefan G. Kertesz, MD, MScRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and Stefan G. Kertesz, MD, MScBirmingham VA Medical Center and University of Alabama at Birmingham School of Medicine, Birmingham, Alabama (S.G.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A21-0011 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses current thinking about the appropriate treatment of patients with substance use disorder with Dr. Stefan Kertesz.Annals articles discussed include...The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline: https://www.acpjournals.org/doi/10.7326/M21-4011Shifting Focus to Evidence-Based Management of Substance Use Disorders: https://www.acpjournals.org/doi/10.7326/M22-0150About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Birmingham VA Medical Center and University of Alabama at Birmingham School of Medicine, Birmingham, Alabama (S.G.K.)Disclosures: Dr. Centor reports consulting fees from DynaMed and employment with the U.S. Department of Veterans Affairs. Dr. Kertesz reports grants from the U.S. Department of Veterans Affairs; royalties or licenses from Wolters Kluwer UpToDate; payment for lectures from St. Vincent's Hospital/Ascension Health, University of Florida, University of Texas Austin College of Pharmacy, University of Nevada, and Medical University of South Carolina; support for attending meetings and/or travel from the University of Nevada and Medical University of South Carolina; an unpaid leadership or fiduciary role with the Science & Policy Advisory Council and National Pain Advocacy Center; and stock or stock options in Zimmer Biomet, Thermo Fisher, Dow, Abbott, Johnson & Johnson, and CVS/Caremark. All relevant financial relationships have been mitigated. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=A21-0011.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Stephanie Chang, MD, MPH, Deputy Editor, reports employment with the Agency for Healthcare Research and Quality, travel compensation from the Guidelines International Network, and participation in the Patient-Centered Outcomes Research Institute methodology committee. Vineet Chopra, MD, MSc, Deputy Editor, reports grants received from the Agency for Healthcare Research and Quality and royalties from UpToDate and Oxford University Press. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he is employed at Johns Hopkins University. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center and consultancy with Boston Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports employment with the Perelman School of Medicine, University of Pennsylvania, and consultancies with the U.S. Food and Drug Administration and the State of Colorado. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoShifting Focus to Evidence-Based Management of Substance Use Disorders Sarah Wakeman The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline Christopher Perry , Joseph Liberto , Charles Milliken , Jennifer Burden , Hildi Hagedorn , Timothy Atkinson , James R. McKay , Larissa Mooney , James Sall , Comilla Sasson , Andrew Saxon , Christopher Spevak , Adam J. Gordon , and Metrics May 2022Volume 175, Issue 5Page: OC1 ePublished: 17 May 2022 Issue Published: May 2022 CopyrightCopyright © 2022 by American College of Physicians. All Rights Reserved.Loading ...